First Time Loading...

Sierra Oncology Inc
NASDAQ:SRRA

Watchlist Manager
Sierra Oncology Inc Logo
Sierra Oncology Inc
NASDAQ:SRRA
Watchlist
Price: 54.99 USD Market Closed
Updated: May 21, 2024

Sierra Oncology Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sierra Oncology Inc
EPS (Diluted) Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Sierra Oncology Inc
NASDAQ:SRRA
EPS (Diluted)
-$4
CAGR 3-Years
45%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
EPS (Diluted)
-$1
CAGR 3-Years
22%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
EPS (Diluted)
-$2
CAGR 3-Years
-15%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
EPS (Diluted)
-$1
CAGR 3-Years
9%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
EPS (Diluted)
$0
CAGR 3-Years
24%
CAGR 5-Years
8%
CAGR 10-Years
-4%
Spectral Medical Inc
TSX:EDT
EPS (Diluted)
CA$0
CAGR 3-Years
-14%
CAGR 5-Years
-43%
CAGR 10-Years
4%

See Also

What is Sierra Oncology Inc's EPS (Diluted)?
EPS (Diluted)
-4.9 USD

Based on the financial report for Mar 31, 2022, Sierra Oncology Inc's EPS (Diluted) amounts to -4.9 USD.

What is Sierra Oncology Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
36%

Over the last year, the EPS (Diluted) growth was 17%. The average annual EPS (Diluted) growth rates for Sierra Oncology Inc have been 45% over the past three years , 36% over the past five years .